Trial Profile
Clinical evaluation of NKQ-01in patients with cancer-related breakthrough pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Nippon Kayaku
- 07 Oct 2015 New trial record